In the present study, we have used the invasive triple-negative human breast cancer cells MDA-MB-231, MDA-MB-436, and BT-549 to investigate the effects of shRNA-mediated NAT1 knockdown on cell morphology and on invasive capacity in vitro. The gene discussed is NAT1; the disease is breast carcinoma.